Jamjoom Pharmaceuticals Factory Co. Board invites its shareholders to attend the Ordinary General Assembly Meeting the (First Meeting)

Element List	Explanation
Introduction	The Board of Directors of Jamjoom Pharmaceuticals Factory Company (“Company”) is pleased to invite its shareholders to attend the Ordinary General Assembly meeting (First Meeting), which is scheduled to be held at six thirty (6:30) PM) on Thursday 04/07/2024G corresponding to 28/12/1445 H from the Company’s headquarter in Jeddah, Online via Tadawulaty Platform (http://tadawulaty.com.sa).
City and Location of the General Assembly's Meeting	Online via Tadawulaty Platform at the headquarters of the Company in the city of Jeddah
Hyperlink of the Meeting Location	Click Here
Date of the General Assembly's Meeting	2024-07-04 Corresponding to 1445-12-28
Time of the General Assembly’s Meeting	18:30
Methodology of Convening the General Assembly’s Meeting	Via modern technology means
Attendance Eligibility, Registration Eligibility, and Voting End	The eligibility to attend the meeting is for shareholders registered in the Company share registry at the Depository Center as of the end of trading prior to the Meeting day, and as per the rules and regulations. The shareholders have the right to discuss matters listed in the agenda of the General Assembly and raise relevant questions. The eligibility for Registering the Attendance of the General Assembly’s Meeting Ends upon the conduction of the General Assembly’s Meeting. The eligibility for Voting on the Meeting Agenda Ends upon the concluding counting committee sorting the Votes.
Quorum for Convening the General Assembly's Meeting	The Ordinary General Assembly meeting shall be valid if attended by shareholders representing at least a quarter of the capital. If the quorum required for holding this meeting is not fulfilled, the second meeting will be held one hour after the end of the period specified for the first meeting, and the second meeting will be valid regardless of the number of shares represented in it.
General Assembly Meeting Agenda	1.Vote on the remunerations for the members of the Board of Directors and the Committees emanating from the Board of Directors, amounting to 2,324,500 Saudi Riyals for the fiscal year ended 31/12/2023. 2.Vote on the contracts and dealings conducted between the Company and Tegan Al-Fateh Factory Company Limited, in which Board Member Mr. Yousuf Mohammed Salah Jamjoom has an indirect interest. This involves an agreement to provide printing services (small cardboard boxes for medicines) under prevailing commercial terms without preferential benefits, noting that the transaction value for the year 2023 amounted to 20,529,024 Saudi Riyals. 3.Vote on the contracts and dealings conducted between the Company and Dream Sky Travel and Tourism Agency, in which the Chairman of the Board, Mr. Mahmoud Yousuf Jamjoom has an indirect interest. This involves providing travel booking services under prevailing commercial terms without preferential benefits, noting that the transaction value for the year 2023 amounted to 11,244,436 Saudi Riyals. 4.Vote on the contracts and dealings that will be conducted between the Company and Dream Sky Travel and Tourism Agency, in which the Chairman of the Board, Mr. Mahmoud Yousuf Jamjoom has an indirect interest. This involves providing advance payments for the year 2023 for travel booking services under prevailing commercial terms without preferential benefits, noting that the advance payment amounting to 4,553,644 Saudi Riyals has been paid for the year 2023 of which 509,602 Saudi Riyals has been paid for the year 2024. 5.Vote on the contracts and dealings that took place between the Company and Jamjoom Algeria Lildawa, in which the Chairman of the Board Mr. Mahmoud Yousuf Jamjoom, the Vice Chairman of the Board Mr. Ahmed Yousuf Jamjoom, and the Board Member, Mr. Mohammed Yousuf Jamjoom, have an indirect interest. These transactions are for the purpose of operational expenses for the joint venture, under prevailing commercial terms and without preferential benefits, noting that the value of expenses for the year 2023 amounted to 821,147 Saudi Riyals.
Proxy Form
The shareholder right in discussing the assembly agenda topics, asking questions, and exercising the voting right	Shareholders are entitled to discuss matters listed in the agenda of the General Assembly and raise relevant questions to the Board members, noting that the voting is free of charge for all Shareholders via: http://tadawulaty.com.sa
Details of the electronic voting on the Assembly’s agenda	Shareholders registered in the Tadawulaty services will be able to vote remotely on the assembly’s agenda. Electronic voting will starting at 1:00AM on Sunday 30/06/ 2024G corresponding to 24/12/1445 H and will last until the end of General assembly time. Please note that registration in Tadawulaty services and voting is free of charge for all shareholders Via the following link: www.tadawulaty.com.sa
Method of Communication in Case of Any Enquiries	For any questions, kindly contact the Investor Relations Department during business hours from 09:00 AM to 05:00 PM at: Tel: +966 12 614 0099 ext. 3313 Mobile: +966 50 985 3577 Email: ir@jamjoompharma.com
Additional Information	With regards to agenda item number 4, we would like to clarify to the respected shareholders that this item is the same item listed as item number 20 from the Extraordinary General Assembly (First Assembly) held on 27/11/1445, corresponding to 04/06/2024. The advance payment transactions between the company and Dream Sky Travel and Tourism Agency during the year 2023 amounted to SAR 4,553,644 the majority of which was for services received during the year 2023 in the amount of SAR 4,044,042 which is included in the total transactions that took place in 2023 SAR 11,244,436 as listed in item number 3 of the agenda of this assembly. As a result, the approval required in item number 4 of this assembly is for the amount of SAR 509,602 for services that will be received in 2024.
Attached Documents